Location History:
- Tubingen, DE (2009)
- Tuebingen, DE (2013)
Company Filing History:
Years Active: 2009-2013
Title: Irina Droste-Borel: Innovator in Biologically Active Compounds
Introduction
Irina Droste-Borel is a prominent inventor based in Tuebingen, Germany. She has made significant contributions to the field of biologically active compounds, holding a total of 2 patents. Her work focuses on enhancing the efficacy of therapeutic agents through innovative methods and formulations.
Latest Patents
Irina's latest patents include a method for identifying improved conjugates of biologically active compounds. This invention features a method that involves incubating a compound in blood cells, separating immune cells from erythrocytic cells, and determining the concentration ratio of the compound in these cells. The compound comprises a transportophore and a therapeutic agent, with the transportophore covalently bonded to the therapeutic agent via a bond or a linker.
Another notable patent involves conjugates of biologically active compounds, methods for their preparation, and their pharmaceutical applications. This invention features a compound with a specific formula that includes a transportophore, a bond or linker, and a non-antibiotic therapeutic agent. The transportophore is designed to have an immune selectivity ratio of at least 2, ensuring enhanced efficacy in therapeutic applications.
Career Highlights
Irina has worked with C-a-i-r Biosciences GmbH, where she has contributed her expertise in the development of biologically active compounds. Her innovative approaches have positioned her as a key figure in her field.
Collaborations
Irina has collaborated with notable professionals such as Michael W Burnet and Jan-Hinrich Guse, further enhancing her research and development efforts in biologically active compounds.
Conclusion
Irina Droste-Borel's contributions to the field of biologically active compounds demonstrate her commitment to innovation and excellence. Her patents reflect her dedication to improving therapeutic efficacy through advanced methodologies.